Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

SARS Pharmaceuticals, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
S

ARS Pharmaceuticals, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

No buy/sell activity
DateNameTitleSharesValueTransactionSource
Oct 1, 2026Casale DonnPresident and CEO1,036,923Stock Option (right to buy)$4.6MGrant / award
Sep 1, 2026Smith Margaret EkinsChief Commercial Officer1,001,738Stock Option (right to buy)$5.9MGrant / award
Jul 1, 2026Casale DonnPresident898,456Stock Option (right to buy)$7.7MGrant / award
Jun 24, 2026Dadoo RajeevDirector30,000Stock Option (right to buy)$289.5KGrant / award
Jun 24, 2026SCHNEIDER PHILLIP MDirector30,000Stock Option (right to buy)$289.5KGrant / award
Jun 24, 2026RA CAPITAL MANAGEMENT, L.P.Director, 10% Owner30,000Stock Option (Right to Buy)$289.5KGrant / award
Jun 24, 2026SAUNDERS BRENT LDirector30,000Stock Option (right to buy)$289.5KGrant / award
Jun 24, 2026Thompson Peter A.Director30,000Stock Option (right to buy)$289.5KGrant / award
Jun 24, 2026Shawver LauraDirector30,000Stock Option (right to buy)$289.5KGrant / award
Jun 24, 2026Islam SaqibDirector30,000Stock Option (right to buy)$289.5KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • News
  • Insider Transactions
$4.48Close · Sep 22, 2026